Trovagene Stock Predictions

Buy TROV

*Your capital is at risk

$2.69

+0 (+0%)

At Close: Jul 20, 2022

Currently predicting for Mon, 8 Jun 2026

TROV Prediction Chart

TROV Predictions History

Latest community submissions for TROV.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jul 22, 2016	$5.18 -91.44%	$5.04	V	97.20%	0
Rodney.Troyer.11	Jul 22, 2016	$5.15 -91.48%	$5.04	V	97.80%	0
Rodney.Troyer.11	Jul 21, 2016	$5.02 -91.77%	$5.08	V	98.80%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TROV with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT TROVAGENE

Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor cell-free DNA using urine or blood samples. It offers Pre...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by